April 2020 ACE2-FC AS A COVID-19 ANTI-VIRAL THERAPYFeaturing: Jing Jin, MD, PhD
Episode SummaryJing Jin, MD, PhD, assistant professor in the Division of Nephrology and Hypertension and his team work to identify pathological mechanisms of kidney and vascular diseases. His work with the therapy ACE2-Fc was recently included in an article published by Robert Kruse, MD, PhD in F1000 Research discussing a potential therapy for the novel coronavirus, COVID-19. In this episode, Jin explains how the therapy could potentially be used to guard against and treat COVID-19 and highlights the important role cross-collaboration plays in facilitating discovery.
|
Jing Jin, MD, PhD, assistant professor in the Division of Nephrology and Hypertension.
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|